SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-114847
Filing Date
2016-04-28
Accepted
2016-04-28 06:05:40
Documents
66
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6516_110q.htm 10-Q 1128734
2 EX-31.1 a16-6516_1ex31d1.htm EX-31.1 14636
3 EX-31.2 a16-6516_1ex31d2.htm EX-31.2 14604
4 EX-31.3 a16-6516_1ex31d3.htm EX-31.3 14624
5 EX-32.1 a16-6516_1ex32d1.htm EX-32.1 8380
6 EX-32.2 a16-6516_1ex32d2.htm EX-32.2 8366
7 EX-32.3 a16-6516_1ex32d3.htm EX-32.3 8367
  Complete submission text file 0001104659-16-114847.txt   6166130

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT uthr-20160331.xml EX-101.INS 1495375
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20160331.xsd EX-101.SCH 47453
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20160331_cal.xml EX-101.CAL 68205
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20160331_def.xml EX-101.DEF 184619
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT uthr-20160331_lab.xml EX-101.LAB 478724
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20160331_pre.xml EX-101.PRE 321011
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 161596970
SIC: 2834 Pharmaceutical Preparations